Form 4: Health Catalyst Director Acquires 4,080 Shares Through Restricted Stock Unit Vesting

Health Catalyst, Inc. Director Duncan Gallagher acquired 4,080 shares of common stock on June 1, 2025, through the vesting of previously granted restricted stock units.

Summary

• Duncan Gallagher, a Director of Health Catalyst, Inc. (HCAT), acquired 4,080 shares of the company's common stock.
• The acquisition occurred on June 1, 2025, and was reported on June 3, 2025.
• The shares were acquired at a price of $0.00, indicating they were part of a non-cash award.
• This transaction represents the vesting of restricted stock units (RSUs) granted under the Issuer's 2019 Stock Option and Incentive Plan.
• Each RSU represents a contingent right to receive one share of common stock, and 100% of these RSUs vested on June 1, 2025.
• Following this transaction, Duncan Gallagher beneficially owns a total of 77,051 shares of Health Catalyst common stock.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive as it reflects a director's increased stake in the company, aligning their interests with shareholders. However, it's a pre-scheduled compensation event (RSU vesting) rather than an open market purchase, which typically carries stronger positive sentiment.

Positives

• The acquisition of shares by a director aligns their interests with those of common shareholders, potentially indicating confidence in the company's long-term performance.
• The vesting of RSUs is a standard component of executive and director compensation, reflecting the company's commitment to its incentive plans.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future financial performance or strategic outlook.

Industry Context

Insider transactions, such as the vesting of restricted stock units, are common in the technology and healthcare sectors as a form of non-cash compensation designed to retain talent and align management incentives with shareholder value. This particular filing is a routine disclosure of such an event.

Stakeholder Impact

• Shareholders: The increased beneficial ownership by a director can be seen as a positive signal, indicating alignment of interests between management and shareholders.

Key Dates

Keywords

Health Catalyst, HCAT, Form 4, Insider Transaction, Beneficial Ownership, Restricted Stock Units, RSU, Director Compensation, Stock Award